Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma Shows Promise

Initial safety data from an ongoing proof-of-concept trial of JCARH125, an investigational BCMA-targeting CAR T being developed by Juno Therapeutics/Celgene Corporation) in patients with...

MEDALIST Trial in Patients with Myelodysplastic Syndromes Shows Statistical Benefit

Data from the pivotal phase III MEDALIST trial (NCT02631070) shows that treatment with luspatercept (ACE-536), an investigational drug for the treatment of patients with...

The Future of Medicine is Bright: Personalized Medicine, Predictive Analytics and...

Modern medicine is to change dramatically. Over the past 200 years medicine has seen extraordinary developments and advances. From microbiology to the sequencing of the...

Patients Diagnosed with Adenomas may not Receive Colonoscopies in Recommended Time...

Results from a recent study presented in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR) and  funded...

Australian Kazia Therapeutics Presents ‘Trial in Progress’ Data for Glioblastoma Study

Results for GDC-0084, an investigational drug being being developed by Australian- based and oncology-focused Kazia Therapeutics, were presented during the annual meeting of the...

Interim Phase II Results of DNX-2401 + Pembrolizumab for Glioblastoma ...

Preliminary results from the CAPTIVE / KEYNOTE-192 study (NCT02798406) dose escalation study evaluating a single intratumoral injection of DNX-2401 (tasadenoturev; DNAtrix) followed by standard...

Scientists, Physicians and Patients Collaborate to Improve Treatment of EGFR-Positive Lung...

The Addario Lung Cancer Medical Institute (ALCMI), Champions Oncology and EGFR Resisters have announced the launch of a new study to create a novel...

Isofol Initiates Pivotal Phase III Clinical Trial of Arfolitixorin for Metastatic...

Sweden-based Isofol Medical has initiated their pivotal Phase III clinical trial, called the ISO-CC-007 study, for the treatment of first-line (initial) metastatic colorectal cancer...

New Test Instrumental in Predicting the Development of Bloodstream Infections in...

Infections are a major cause of morbidity and mortality in pediatric cancer patients. And patients undergoing treatment for...

How to Better Utilize the Immune System – Neoadjuvant Therapy to...

It's a question that begs being answered: Can physicians use immunotherapy more effectively? The answer may be a simple 'Yes.' In the treatment of a number...

Latest